Redhill Biopharma (RDHL)
(Delayed Data from NSDQ)
$0.46 USD
0.00 (-0.04%)
Updated May 31, 2024 03:56 PM ET
After-Market: $0.45 -0.01 (-1.77%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Redhill Biopharma Ltd. [RDHL]
Reports for Purchase
Showing records 41 - 60 ( 228 total )
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
COVID-19 challenges and opportunities
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Transforming into a commercial pharma company
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Talicia and Movantik Launches Imminent; Adjust PT to $14.00; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
2020 set to be a commercially transformative year
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Preparations Ready for Aemcolo and Talicia Launches; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Aemcolo and Talicia Launches Expected in 4Q19 and 1Q20; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Talicia Approved; Launch Expected in 1Q20; New PT $18.00; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Cosmo deal - new asset, stronger balance sheet
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
Company: Redhill Biopharma Ltd.
Industry: Medical - Drugs
We See Cosmo Agreement as a Vote of Confidence; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S